Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Thrombotic Microangiopathies

• Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
• Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA
• Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation
• Multicenter, Uncontrolled Pilot Study Evaluating the Efficacy of Eculizumab in the Treatment of Gemcitabine-induced Thrombotic Microangiopathies
• Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus
• A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation (HSCT)
• Nomacopan (rVA576) in Transplant Associated Thrombotic Microangiopathy
• Ravulizumab and COVID-19
• Study of Ravulizumab in Pediatric Participants With HSCT-TMA
• Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant
• Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
• Defibrotide TMA Prophylaxis Pilot Trial
• A Safety and Efficacy Study of NAC in Patients With TA-TMA
• Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants
• Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy